scPharmaceuticals Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
scPharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • scPharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was -202 %, a 174% decline year-over-year.
  • scPharmaceuticals Inc. annual Return On Equity for 2023 was -97.2 %, a 27.5% decline from 2022.
  • scPharmaceuticals Inc. annual Return On Equity for 2022 was -76.2 %, a 79.5% decline from 2021.
  • scPharmaceuticals Inc. annual Return On Equity for 2021 was -42.5 %, a 7.14% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -97.2 -21 -27.5% Jan 1, 2023 Dec 31, 2023
2022 -76.2 -33.7 -79.5% Jan 1, 2022 Dec 31, 2022
2021 -42.5 -2.83 -7.14% Jan 1, 2021 Dec 31, 2021
2020 -39.6 +14.7 +27% Jan 1, 2020 Dec 31, 2020
2019 -54.3 -20.5 -60.7% Jan 1, 2019 Dec 31, 2019
2018 -33.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.